SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-050656
Filing Date
2021-04-15
Accepted
2021-04-15 13:30:25
Documents
43
Period of Report
2021-04-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113070d1_8k.htm   iXBRL 8-K 25304
2 EXHIBIT 99.1 tm2113070d1_ex99-1.htm EX-99.1 49132
6 GRAPHIC tm2113070d1_ex99-1g001.jpg GRAPHIC 61252
7 GRAPHIC tm2113070d1_ex99-1g002.jpg GRAPHIC 180777
8 GRAPHIC tm2113070d1_ex99-1g003.jpg GRAPHIC 85905
9 GRAPHIC tm2113070d1_ex99-1g004.jpg GRAPHIC 76276
10 GRAPHIC tm2113070d1_ex99-1g005.jpg GRAPHIC 64109
11 GRAPHIC tm2113070d1_ex99-1g006.jpg GRAPHIC 54432
12 GRAPHIC tm2113070d1_ex99-1g007.jpg GRAPHIC 72313
13 GRAPHIC tm2113070d1_ex99-1g008.jpg GRAPHIC 89394
14 GRAPHIC tm2113070d1_ex99-1g009.jpg GRAPHIC 94233
15 GRAPHIC tm2113070d1_ex99-1g010.jpg GRAPHIC 72888
16 GRAPHIC tm2113070d1_ex99-1g011.jpg GRAPHIC 53356
17 GRAPHIC tm2113070d1_ex99-1g012.jpg GRAPHIC 82709
18 GRAPHIC tm2113070d1_ex99-1g013.jpg GRAPHIC 84986
19 GRAPHIC tm2113070d1_ex99-1g014.jpg GRAPHIC 78836
20 GRAPHIC tm2113070d1_ex99-1g015.jpg GRAPHIC 72434
21 GRAPHIC tm2113070d1_ex99-1g016.jpg GRAPHIC 84333
22 GRAPHIC tm2113070d1_ex99-1g017.jpg GRAPHIC 55269
23 GRAPHIC tm2113070d1_ex99-1g018.jpg GRAPHIC 90945
24 GRAPHIC tm2113070d1_ex99-1g019.jpg GRAPHIC 73983
25 GRAPHIC tm2113070d1_ex99-1g020.jpg GRAPHIC 94006
26 GRAPHIC tm2113070d1_ex99-1g021.jpg GRAPHIC 53011
27 GRAPHIC tm2113070d1_ex99-1g022.jpg GRAPHIC 86430
28 GRAPHIC tm2113070d1_ex99-1g023.jpg GRAPHIC 104914
29 GRAPHIC tm2113070d1_ex99-1g024.jpg GRAPHIC 66467
30 GRAPHIC tm2113070d1_ex99-1g025.jpg GRAPHIC 52427
31 GRAPHIC tm2113070d1_ex99-1g026.jpg GRAPHIC 59461
32 GRAPHIC tm2113070d1_ex99-1g027.jpg GRAPHIC 85536
33 GRAPHIC tm2113070d1_ex99-1g028.jpg GRAPHIC 80559
34 GRAPHIC tm2113070d1_ex99-1g029.jpg GRAPHIC 50585
35 GRAPHIC tm2113070d1_ex99-1g030.jpg GRAPHIC 81872
  Complete submission text file 0001104659-21-050656.txt   3495685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbrv-20210415.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbrv-20210415_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbrv-20210415_pre.xml EX-101.PRE 22709
36 EXTRACTED XBRL INSTANCE DOCUMENT tm2113070d1_8k_htm.xml XML 3502
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 21828061
SIC: 2834 Pharmaceutical Preparations